Patents by Inventor Mirza Peljto

Mirza Peljto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10504224
    Abstract: The human vision is limited in terms of perception of color hues and intensities. Moreover, the individual's ability in this context varies greatly from person to person. Herein are described methods to quantify staining of tissue samples via digital tissue image analysis, when staining of a certain biomarker is below or at the threshold of human visual perception, in terms of saturation. This enables for consistent detection of these staining characteristics, which allows for more reproducible data generation through minimizing inter- and intra-observer variability.
    Type: Grant
    Filed: December 31, 2016
    Date of Patent: December 10, 2019
    Assignee: Flagship Biosciences, Inc.
    Inventors: Famke Aeffner, Joseph Krueger, Mirza Peljto
  • Patent number: 9298968
    Abstract: This disclosure concerns methods for evaluating inflammatory cells and modulators of the inflammatory response in tumor tissue and other relevant tissue types. The methods entail: obtaining a tissue sample and processing said tissue sample to produce histologic slides of tissue sections; staining of the tissue sections to identify inflammatory cells and modulators of the inflammatory response; digitizing slides to produce an image of the stained tissue sections; digitally stratifying the tissue sample into tumor and other relevant tissue compartments; and using digital image analysis to quantify cell-based and cell population-based features. The quantification of cell-based and cell population-based features within a tissue compartment of interest is used to develop a summary score of the immune system-tissue compartment of interest interaction. Patient stratification and selection as candidates for a therapeutic approach is ultimately based on the summary score value.
    Type: Grant
    Filed: December 31, 2014
    Date of Patent: March 29, 2016
    Assignee: FLAGSHIP BIOSCIENCES, INC.
    Inventors: Mirza Peljto, Anthony J. Milici, Holger Lange, Joseph Krueger, Famke Aeffner, George D. Young, Nathan T. Martin
  • Patent number: 8969081
    Abstract: Disclosed are methods for generating a neuron expressing Hoxc8 transcription factor or a caudal motor neuron comprising culturing an embryonic stem cell in a composition which is essentially free of retinoids and comprises an isotonic salt solution, so as to generate the neuron which expresses Hoxc8 transcription factor or the caudal motor neuron. Disclosed are also methods for generating a caudal brachial motor neuron, a thoracic motor neuron, or a lumbar motor neuron from an embryonic stem cell in a composition essentially free of retinoids and comprising ADFNK medium, an amount of FGF-2, or Gdf11 respectively. Disclosed are also methods of transplanting a motor neuron into a subject comprising generating the motor neuron and transplanting the motor neuron into the subject. Disclosed is also a population of motor neuron cells enriched for motor neuron cells expressing Foxp1 and expressing a gene associated with Spinal Muscular Atrophy (SMA) or Amyotrophic Lateral Sclerosis (ALS).
    Type: Grant
    Filed: December 9, 2009
    Date of Patent: March 3, 2015
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Hynek Wichterle, Thomas M. Jessell, Mirza Peljto
  • Publication number: 20100196332
    Abstract: Disclosed are methods for generating a neuron expressing Hoxc8 transcription factor or a caudal motor neuron comprising culturing an embryonic stem cell in a composition which is essentially free of retinoids and comprises an isotonic salt solution, so as to generate the neuron which expresses Hoxc8 transcription factor or the caudal motor neuron. Disclosed are also methods for generating a caudal brachial motor neuron, a thoracic motor neuron, or a lumbar motor neuron from an embryonic stem cell in a composition essentially free of retinoids and comprising ADFNK medium, an amount of FGF-2, or Gdf11 respectively. Disclosed are also methods of transplanting a motor neuron into a subject comprising generating the motor neuron and transplanting the motor neuron into the subject. Disclosed is also a population of motor neuron cells enriched for motor neuron cells expressing Foxp1 and expressing a gene associated with Spinal Muscular Atrophy (SMA) or Amyotrophic Lateral Sclerosis (ALS).
    Type: Application
    Filed: December 9, 2009
    Publication date: August 5, 2010
    Inventors: Hynek Wichterle, Thomas M. Jessell, Mirza Peljto